| Authors: |
Schultheis B; Department of Hematology/Oncology, University Bochum, Marien Hospital Herne, Herne;. Electronic address: beate.schultheis@elisabethgruppe.de., Reuter D; Oncoscience AG, Wedel (recently Schenefeld)., Ebert MP; Klinikum Rechts der Isar TU München, München., Siveke J; Klinikum Rechts der Isar TU München, München., Kerkhoff A; University Hospital Münster, Münster., Berdel WE; University Hospital Münster, Münster., Hofheinz R; Department of Hematology and Medical Oncology, University Medical Center Mannheim, Mannheim., Behringer DM; Augusta-Kranken-Anstalt, Bochum., Schmidt WE; St. Josef Hospital, Med. Klinik I, Bochum, Germany., Goker E; Ege University Medical School, Izmir, Turkey., De Dosso S; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Kneba M; Department of Medicine, University Medical Center Schleswig-Holstein, Kiel, Germany., Yalcin S; Hacettepe University Hospital, Ankara, Turkey., Overkamp F; Medical Practice for Oncology and Hematology, Recklinghausen., Schlegel F; St. Antonius Hospital, Eschweiler., Dommach M; Sana-Kliniken, Medizinisches Versorgungszentrum Onkologie, Düsseldorf., Rohrberg R; Gemeinschaftspraxis und Tagesklinik fuer Haematologie, Onkologie und Gastroenterologie, Halle., Steinmetz T; Group Practice Hematology/Oncology Cologne, Cologne., Bulitta M; CRM Biometrics GmbH, Rheinbach, Germany., Strumberg D; Department of Hematology/Oncology, University Bochum, Marien Hospital Herne, Herne. |
